Array Behavioral Care Launches Rapid Care for Urgent Needs
Philadelphia, Pennsylvania, U.S., September 18, 2026 Array Behavioral Care, a provider of virtual behavioral health services, has introduced Array...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Philadelphia, Pennsylvania, U.S., September 18, 2026 Array Behavioral Care, a provider of virtual behavioral health services, has introduced Array...
Orlando, Florida, USA, August, 10, 2026 Independent research from the Medical University of South Carolina (MUSC) Telehealth Center of...
BOSTON, Mass., July 7, 2026 Handspring Health has secured $19 million in Series B financing, with Angelini Ventures participating...
SAN JOSE, California, July 2, 2026 Visby Medical has received U.S. Food and Drug Administration (FDA) clearance for the...
OMER, Israel & LOS ANGELES, Feb. 2, 2026 — Pulsenmore Ltd., a pioneer in home-use ultrasound and remote prenatal...
NEW YORK, September 8, 2025 — Biotia has introduced an innovative “test to treat” pathway for patients suffering from...
